Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease.

Abstract:

:Gaucher disease (GD) is a lysosomal storage disorder; symptomatic patients with type 1 GD need long-term disease-specific therapy of which the standard of care has been enzyme replacement therapy (ERT). Thirty-eight of 40 patients (aged 9-71 years) clinically stable on ERT with imiglucerase, safely switched to a comparable dose of velaglucerase alfa (units/kg) during TKT034, a 12-month, open-label clinical study, and for 10-50 months in an extension study. The most common adverse events (AEs) judged to be drug-related in the extension were fatigue and bone pain. No drug-related serious AEs were reported. No AEs led to study withdrawal. At 24 months from baseline (baseline being TKT034 week 0), patients had generally stable hemoglobin, platelet, spleen, liver, and bone density parameters. Nevertheless, dose adjustment based on the achievement of therapeutic goals was permitted, and 10 patients, including seven patients who had platelet counts <100 × 10(9) /L at baseline, were given at least one 15 U/kg-dose increase during the extension. Trends indicative of improvement in platelet count and spleen volume, and decreasing levels of GD biomarkers, chitotriosidase and CCL18, were observed. Immunogenicity was seen in one patient positive for anti-imiglucerase antibodies at baseline. This patient tested positive for anti-velaglucerase alfa antibodies in TKT034, with low antibody concentrations, and throughout the extension study; however, the patient continued to receive velaglucerase alfa without clinical deterioration. In conclusion, clinically stable patients can be switched from imiglucerase to velaglucerase alfa ERT and maintain or achieve good therapeutic outcomes.

journal_name

Am J Hematol

authors

Elstein D,Mehta A,Hughes DA,Giraldo P,Charrow J,Smith L,Shankar SP,Hangartner TN,Kunes Y,Wang N,Crombez E,Zimran A

doi

10.1002/ajh.24007

subject

Has Abstract

pub_date

2015-07-01 00:00:00

pages

592-7

issue

7

eissn

0361-8609

issn

1096-8652

journal_volume

90

pub_type

临床试验,杂志文章
  • Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia.

    abstract::Intravenous immunoglobulin (IVIG) therapy is associated with rare reports of thromboembolic events and severe hyponatremia. We hypothesized that IVIG therapy may result in hyperproteinemia, increased serum viscosity, and pseudohyponatremia. We conducted a prospective observational study to evaluate the incidence of hy...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10325

    authors: Steinberger BA,Ford SM,Coleman TA

    更新日期:2003-06-01 00:00:00

  • Evidence that less replacement therapy is required for dental extractions in hemophiliacs.

    abstract::The requirements for factor VIII (AHF) or factor IX (PTC) of hemophilic patients undergoing dental extractions were evaluated to determine the minimum effective regimen. Sixteen patients underwent 19 operative procedures. The mean total dose of factor VIII or IX was 45.8 U/kg for 11 procedures with preoperative replac...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830160102

    authors: Steinberg SE,Levin J,Bell WR

    更新日期:1984-01-01 00:00:00

  • Change of enzyme properties caused by cross-linking treatment of human erythrocytes.

    abstract::Aragon et al [4] reported that rat erythrocytes can be cross-linked and permeabilized without significant inactivation or alterations of several enzymes in the glycolytic pathway. If this is the case, in situ kinetic analysis of the red cell enzymes in normal human red cells and abnormal red cells associated with hemo...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830130103

    authors: Ikawa M,Yoshida A

    更新日期:1982-08-01 00:00:00

  • Monocytic leukemia cutis diagnosed simultaneously with refractory anemia with monocytosis: a case report.

    abstract::A case of leukemia cutis (LC) of monocytic lineage in a patient with myelodysplastic syndrome (MDS) is presented. Cutaneous infiltrates were recognized concurrent with diagnosis of refractory anemia (RA) with monocytosis. Skin infiltrates subsequently spontaneously regressed although MDS progressed with increasing mon...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/1096-8652(200102)66:2<120::AID-AJH1027>3.0

    authors: Yavorkovsky LL,Zain J,Wu CD,Trivelli L,Cook P

    更新日期:2001-02-01 00:00:00

  • Dense red blood cell and oxygen desaturation in sickle-cell disease.

    abstract::Production of abnormal hemoglobin (HbS) in sickle-cell disease (SCD) results in its polymerization in deoxygenated conditions and in sickled-RBC formation. Dense RBCs (DRBCs), defined as density >1.11 and characterized by increased rigidity are absent in normal AA subjects, but present at percentages that vary of a pa...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24467

    authors: Di Liberto G,Kiger L,Marden MC,Boyer L,Poitrine FC,Conti M,Rakotoson MG,Habibi A,Khorgami S,Vingert B,Maitre B,Galacteros F,Pirenne F,Bartolucci P

    更新日期:2016-10-01 00:00:00

  • Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.

    abstract::Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with isolated thrombocytopenia and hemorrhagic risk. While many children with ITP can be safely observed, treatments are often needed for various reasons, including to decrease bleeding, or to improve health related quality of life (HRQoL). There are a n...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.25479

    authors: Grace RF,Shimano KA,Bhat R,Neunert C,Bussel JB,Klaassen RJ,Lambert MP,Rothman JA,Breakey VR,Hege K,Bennett CM,Rose MJ,Haley KM,Buchanan GR,Geddis A,Lorenzana A,Jeng M,Pastore YD,Crary SE,Neier M,Neufeld EJ,Neu N

    更新日期:2019-07-01 00:00:00

  • Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome.

    abstract::Eosinophilia associated with solid tumors is an infrequent occurrence. The pathogenesis of tumor-associated eosinophilia is not well understood. Interleukin-5 (IL-5) is a cytokine that has been implicated in the development of eosinophilia in mice and humans. However, there is little data associating IL-5 production w...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20789

    authors: Pandit R,Scholnik A,Wulfekuhler L,Dimitrov N

    更新日期:2007-03-01 00:00:00

  • Improved method for diagnosis of polycythemia vera based on flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture.

    abstract::"Autonomous" development of erythroid colonies in erythropoietin (EPO)-free semi-solid culture has been used as an in vitro assay for diagnosis of polycythemia vera (PV). These colonies, however, are small and poorly hemoglobinized, rendering the assay in many cases unreliable. We report here on the use of a novel ass...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199701)54:1<47::aid-ajh7>3

    authors: Manor D,Rachmilewitz EA,Fibach E

    更新日期:1997-01-01 00:00:00

  • Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: higher concentrations in angioimmunoblastic T-cell lymphoma.

    abstract::The soluble form of Fas (sFas) can block apoptosis induced by the Fas ligand in vitro. A recent report demonstrated that mice injected with sFas displayed autoimmune features. Therefore, an elevated serum concentration of sFas may be associated with lymphoproliferation and autoimmune diseases. We measured the serum co...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199808)58:4<334::aid-ajh15

    authors: Yufu Y,Choi I,Hirase N,Tokoro A,Noguchi Y,Goto T,Uike N,Kozuru M

    更新日期:1998-08-01 00:00:00

  • Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.

    abstract::Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients. Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 medically ill patients have highlighted the risk of VTE in this group. These trials have helped to define a specific at-risk patient prof...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20281

    authors: Stinnett JM,Pendleton R,Skordos L,Wheeler M,Rodgers GM

    更新日期:2005-03-01 00:00:00

  • Acquired pulmonary alveolar proteinosis after umbilical cord blood transplantation for acute myeloid leukemia.

    abstract::Pulmonary alveolar proteinosis (PAP) is a heterogeneous disease that occasionally develops with hematological malignancy. However, PAP in association with hematopoietic stem cell transplantation is quite rare. Here we present the first report of a patient who developed PAP after cord blood transplantation (CBT). A 45-...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10107

    authors: Tomonari A,Shirafuji N,Iseki T,Ooi J,Nagayama H,Masunaga A,Tojo A,Tani K,Asano S

    更新日期:2002-06-01 00:00:00

  • Lenalidomide in multiple myeloma: Current status and future potential.

    abstract::The clinical development of lenalidomide (Revlimid™), then pomalidomide (Actimid™) as members of immunomodulatory drugs (IMiDs) for the treatment of multiple myeloma (MM), exemplifies how insight into disease biology can lead to design of effective therapeutic agents. Increased experience and understanding of IMiD's d...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.23234

    authors: Quach H,Kalff A,Spencer A

    更新日期:2012-12-01 00:00:00

  • Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: case report and review of literature.

    abstract::Thalidomide is being increasingly used in hematology and oncology. Its use is associated with neuropathy, sedation, edema, fatigue, constipation, and deep venous thrombosis. Cytopenias are unusual, but there are case reports. However, there are no reports of isolated thrombocytopenia. We describe here a case of prolon...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.20949

    authors: Prasad HK,Kaushal V,Mehta P

    更新日期:2007-09-01 00:00:00

  • New alpha 2 globin chain variant with low oxygen affinity affecting the N-terminal residue and leading to N-acetylation [Hb Lyon-Bron alpha 1(NA1)Val --> Ac-Ala].

    abstract::Hemoglobin Lyon-Bron was found in two members of a family of German ascent presenting with a moderate normocytic anemia. In this alpha 2 globin variant, the N-terminal valine of the chain was replaced by an alanine. Electrospray mass spectrometry of the alpha chain showed that, as normally, the initiator methionine wa...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10051

    authors: Lacan P,Souillet G,Aubry M,Promé D,Richelme-David S,Kister J,Wajcman H,Francina A

    更新日期:2002-03-01 00:00:00

  • Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma.

    abstract::Conventional treatment of mantle cell lymphoma (MCL) yields modest responses and short remissions. We report 30 hematopoietic stem cell transplants (HSCT) for MCL: 13 autologous, 10 allogeneic myeloablative, and 7 nonablative. After a median 1.2 years from diagnosis (range 0.5 to 4.7) and a median of 2 pre-HSCT chemot...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20646

    authors: Laudi N,Arora M,Burns L,McGlave P,Miller J,Bohac G,Rogers T,Barker J,Coad J,Weisdorf D

    更新日期:2006-07-01 00:00:00

  • Serum-free culture of human hemopoietic progenitors in attenuated culture media.

    abstract::To elucidate the precise mechanisms of molecular and cellular regulation of hemopoiesis, it is necessary to develop a chemically defined culture assay for purified hemopoietic progenitors. To approach this long-term goal, we attempted to develop a serum-free culture system for enriched human progenitors that permits e...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830280404

    authors: Sonoda Y,Ogawa M

    更新日期:1988-08-01 00:00:00

  • Exposure to phorbol diester (TPA) in vitro as an aid in the classification of blasts in human myelogenous and lymphoid leukemias: in vitro differentiation, growth patterns, and ultrastructural observations.

    abstract::Leukemic cells from the peripheral blood of 52 patients with acute and chronic leukemias were incubated with 12-0-tetradecanoyl phorbol ester (TPA). Thirty-one cases of lymphocytic leukemia (18 cases of acute lymphoblastic and 13 cases of chronic lymphocytic leukemia), 13 cases of acute nonlymphoblastic (myelo or myel...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830130303

    authors: Polliack A,Leizerowitz R,Korkesh A,Gurfel D,Gamliel H,Galili U

    更新日期:1982-11-01 00:00:00

  • A serum ferritin assay for prevalence studies of iron deficiency.

    abstract::A specialized serum ferritin assay has been developed for the detection of iron deficiency in epidemiologic studies. An enzyme immunoassay (EIA) was employed to eliminate the need for radioisotopes. The problem of low sensitivity inherent with the EIA for serum ferritin was eliminated by the use of monoclonal immunolo...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830230209

    authors: Flowers CA,Kuizon M,Beard JL,Skikne BS,Covell AM,Cook JD

    更新日期:1986-10-01 00:00:00

  • Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke.

    abstract::Chronic transfusion therapy is the treatment of choice for preventing stroke recurrence in children with sickle cell disease (SCD). The majority of children affected by this devastating complication live in the developing world where access to regular blood transfusions may be impractical. Since 2000, in the absence o...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.22142

    authors: Ali SB,Moosang M,King L,Knight-Madden J,Reid M

    更新日期:2011-10-01 00:00:00

  • Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers.

    abstract::Granulocyte-macrophage colony-stimulating factor (GM-CSF) (250 microg/m2) was administered subcutaneously to 7 normal volunteers for up to 14 days to study its effects on neutrophil kinetics and function. With treatment, blood neutrophil counts rose gradually to peak at 3 1/2 times baseline by day 14. At day 5 marrow ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199801)57:1<7::aid-ajh2>3.

    authors: Dale DC,Liles WC,Llewellyn C,Price TH

    更新日期:1998-01-01 00:00:00

  • MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.

    abstract::A 77-year-old caucasian man presented on March 2005 with important epigastric pain without any other significant history of gastritis. Patient refers a history of cutaneous Kaposi's sarcoma (KS) treated since 1974 with surgical excision or oncovorin topical injection. He underwent endoscopic evaluation showing a 1.5-c...

    journal_title:American journal of hematology

    pub_type: 信件

    doi:10.1002/ajh.21802

    authors: Mirabile A,Devizzi L,Gianni AM,Cabras A,Carbone A

    更新日期:2010-10-01 00:00:00

  • beta-Thalassemia arising as a new mutation in an American child.

    abstract::A 6-year-old child of northern European ancestry was found to have microcytic, hypochromic anemia with an elevated level of hemoglobin A2 and an unbalanced pattern of globin chain synthesis characteristic of beta-thalassemia trait. Hematologic and globin synthesis studies of both parents yielded entirely normal result...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830040211

    authors: Nronha PA,Honig GR

    更新日期:1978-01-01 00:00:00

  • CD7, CD34-positive stem cell leukemia arising in agnogenic myeloid metaplasia.

    abstract::Agnogenic myeloid metaplasia (AMM) is a chronic myeloproliferative disorder arising from a single hematopoietic cell. Approximately 5% of reported cases of AMM have terminated in leukemic crisis; however, the precise characteristics of the leukemic cells have rarely been reported. We report a case of AMM that occurred...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830440111

    authors: Tasaka T,Nagai M,Murao S,Yamaguchi M,Kitanaka A,Sasaki K,Murata M,Tanaka T,Kuwabara H,Ikeda K

    更新日期:1993-09-01 00:00:00

  • Natural history of acquired immunodeficiency syndrome in hemophilic patients.

    abstract::During the 5-year period from 1981 to 1985, we have observed 8 cases of acquired immunodeficiency syndrome (AIDS) among our 85 patients with hemophilia A. Thus, the prevalence of AIDS with hemophilia A is 9.4% in our patient population. By utilizing stored serum or plasma samples dating back to 1978, antibody against ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830240208

    authors: Kim HC,Nahum K,Raska K Jr,Gocke DJ,Kosmin M,Karp GI,Saidi P

    更新日期:1987-02-01 00:00:00

  • Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy.

    abstract::Endothelin-1 (Et-1) is a vasoconstrictor produced by endothelial and vascular smooth muscle cells in response to hypoxia, which induces hypertrophy in cultured cardiac myocytes. We measured plasma Et-1 levels and left ventricular dimensions in 13 patients with sickle cell anemia (SCD) and in 12 African-American contro...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199807)58:3<195::aid-ajh6>

    authors: Werdehoff SG,Moore RB,Hoff CJ,Fillingim E,Hackman AM

    更新日期:1998-07-01 00:00:00

  • Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.

    abstract::Antithymocyte globulins (ATG) plus cyclosporine (CSA) is the gold standard immunosuppressive treatment (IST) for patients with aplastic anemia. A prospective randomized trial showed in 2011 that hATG was superior to rabbit ATG for first-line treatment of severe AA. The French Health Agency (ANSM) permitted a patient-n...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.25050

    authors: Peffault de Latour R,Tabrizi R,Marcais A,Leblanc T,Lamy T,Mohty M,Tavitian S,Jubert C,Pasquet M,Galambrun C,Nguyen S,Cahn JY,Braun T,Deconinck E,Bay JO,Sicre de Fontbrune F,Barraco F,Socié G

    更新日期:2018-05-01 00:00:00

  • Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.

    abstract::Children with sickle cell anemia (SCA) and a primary overt stroke are at high risk of recurrent (secondary) stroke. Chronic transfusion therapy dramatically reduces but does not eliminate this high risk, and inevitably results in transfusion-related hemosiderosis. We previously reported the use of hydroxyurea/phleboto...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21986

    authors: Greenway A,Ware RE,Thornburg CD

    更新日期:2011-04-01 00:00:00

  • Spontaneous erythroid colony formation in Brazilian patients with sickle cell disease.

    abstract::The ability of circulating progenitor cells to develop erythroid colonies was studied in vitro in the presence or absence of growth factors (5637-CM and erythropoietin) in 63 patients with sickle cell disease (SCD) (36 homozygotes for hemoglobin [Hb] S, 13 double heterozygotes for Hb S and beta thalassemia, and 14 SC ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199905)61:1<40::aid-ajh8>3

    authors: Perlingeiro RC,Costa FF,Saad ST,Arruda VR,Queiroz ML

    更新日期:1999-05-01 00:00:00

  • Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.

    abstract:DISEASE OVERVIEW:Chronic neutrophilic leukemia (CNL) is a rare, often aggressive myeloproliferative neoplasm (MPN) defined by persistent mature neutrophilic leukocytosis, bone marrow granulocyte hyperplasia, and frequent hepatosplenomegaly. The seminal discovery of oncogenic driver mutations in colony-stimulating facto...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.25688

    authors: Szuber N,Elliott M,Tefferi A

    更新日期:2020-02-01 00:00:00

  • Measurement of human serum erythropoietin by erythroid colony-forming technique using fetal mouse liver cells.

    abstract::A quantitative bioassay for serum erythropoietin in anemic patients was established with erythroid colony-forming technique using methyl cellulose. Fetal mouse liver contains many erythropoietin-dependent erythroid colony-forming cells (CFU-E) with the concentration as well as sensitivity to erythropoietin being the h...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830120210

    authors: Okamoto T,Kanamaru A,Hara H,Nagai K

    更新日期:1982-04-01 00:00:00